Proto Labs Inc (PRLB)
Official siteINDUSTRIALS • METAL FABRICATION • NYSE
Market Cap: $1.61B
Last updated: Nov 17, 2026 at 11:06 AM ET
Proto Labs Inc (PRLB) Financials: Revenue, Profit and Cash Flow
Proto Labs reported revenue of $533.13M for the fiscal year ended Dec 31, 2025, up 6.4% from the year before. That year, net income was $21.24M with a net margin of 4.0%, operating cash flow was $74.50M and free cash flow was $59.66M. The quarter ended Sep 30, 2026 had revenue of $154.32M and net income of $11.76M.
Revenue and Margins
The operating margin was 4.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $298.06M, a compound annual rate of 6.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $533.13M | +6.4% | 44.5% | 4.7% | 4.0% |
| Dec 2024 | $500.89M | -0.6% | 44.6% | 4.0% | 3.3% |
| Dec 2023 | $503.88M | +3.2% | 44.1% | 5.6% | 3.4% |
| Dec 2022 | $488.40M | +0.1% | 44.1% | -20.1% | -21.2% |
| Dec 2021 | $488.10M | +12.4% | 45.6% | 8.3% | 6.8% |
| Dec 2020 | $434.39M | -5.3% | 50.1% | 13.8% | 11.7% |
| Dec 2019 | $458.73M | +2.9% | 51.3% | 17.4% | 13.9% |
| Dec 2018 | $445.60M | +29.3% | 53.6% | 20.0% | 17.2% |
| Dec 2017 | $344.49M | +15.6% | 56.3% | 21.0% | 15.0% |
| Dec 2016 | $298.06M | N/A | 56.0% | 20.7% | 14.3% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 28.0% from the year before. In the quarter ended Sep 2026, net income rose 62.9% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $533.13M | $500.89M | $503.88M | $488.40M | $488.10M | $434.39M | $458.73M | $445.60M | $344.49M | $298.06M |
| Cost of revenue | $295.99M | $277.69M | $281.88M | $272.93M | $265.41M | $216.57M | $223.44M | $206.92M | $150.65M | $131.12M |
| Gross profit | $237.14M | $223.20M | $221.99M | $215.47M | $222.69M | $217.83M | $235.29M | $238.68M | $193.84M | $166.94M |
| Research and development | $42.81M | $41.30M | $40.13M | $38.22M | $44.24M | $36.94M | $32.69M | $28.73M | $23.56M | $22.39M |
| Operating income | $25.11M | $19.91M | $28.17M | -$97.98M | $40.34M | $59.84M | $79.86M | $88.90M | $72.23M | $61.77M |
| Net income | $21.24M | $16.59M | $17.22M | -$103.46M | $33.37M | $50.87M | $63.66M | $76.59M | $51.78M | $42.71M |
| EBITDA | $64.88M | $60.48M | $65.48M | -$58.45M | $80.67M | $95.54M | $112.06M | $118.78M | $93.97M | $82.88M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $154.32M | $149.34M | $139.34M | $136.49M | $135.37M | $135.06M | $126.20M | $121.75M | $125.62M | $125.63M | $127.89M | $125.05M |
| Gross profit | $68.66M | $69.34M | $63.59M | $60.37M | $61.29M | $59.77M | $55.70M | $51.96M | $57.23M | $56.55M | $57.47M | $55.81M |
| Operating income | $14.44M | $11.36M | $9.84M | $6.80M | $8.81M | $4.97M | $4.53M | -$1.50M | $8.58M | $6.00M | $6.83M | $8.39M |
| Net income | $11.76M | $9.15M | $8.11M | $6.00M | $7.22M | $4.43M | $3.60M | -$404.00K | $7.19M | $4.54M | $5.27M | $6.99M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $1.44M by $109.39M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $763.41M | $743.51M | $772.35M | $802.17M | $928.58M | $744.20M | $673.67M | $618.99M | $518.74M | $414.24M |
| Current assets | $233.54M | $194.85M | $200.66M | $186.57M | $183.49M | $242.00M | $236.42M | $215.36M | $165.00M | $157.78M |
| Cash and equivalents | $110.83M | $89.07M | $83.79M | $56.56M | $65.93M | $127.60M | $125.22M | $85.05M | $36.71M | $68.80M |
| Total liabilities | $89.48M | $73.36M | $77.06M | $104.52M | $100.09M | $99.85M | $87.88M | $77.49M | $57.52M | $34.41M |
| Short-term debt | $1.44M | $1.60M | $1.88M | $19.10M | $3.85M | $3.82M | $3.34M | N/A | $5.00M | $0 |
| Shareholder equity | $673.93M | $670.15M | $695.29M | $697.65M | $828.49M | $644.36M | $585.79M | $541.50M | $461.21M | $379.83M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $808.02M | $791.30M | $778.57M | $760.36M | $756.86M | $743.25M | $737.45M | $743.51M | $753.79M | $758.21M | $769.80M | $772.35M |
| Total liabilities | $106.22M | $99.56M | $95.44M | $89.48M | $92.14M | $78.55M | $80.65M | $73.36M | $73.79M | $72.97M | $82.49M | $77.06M |
| Cash and equivalents | $133.78M | $127.92M | $123.97M | $110.83M | $104.42M | $90.38M | $82.69M | $89.07M | $87.87M | $96.15M | $92.80M | $83.79M |
| Shareholder equity | $701.80M | $691.73M | $683.13M | $670.87M | $664.72M | $664.71M | $656.80M | $670.15M | $679.99M | $685.24M | $687.31M | $695.29M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 80.1% of operating cash flow. Share repurchases came to 72.0% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $74.50M | $77.83M | $73.27M | $62.08M | $55.24M | $106.97M | $116.05M | $122.93M | $81.75M | $77.50M |
| Capital expenditures | $14.84M | $9.17M | $28.12M | $21.69M | $34.21M | $47.01M | $62.23M | $87.10M | $32.63M | $33.62M |
| Free cash flow | $59.66M | $68.66M | $45.16M | $40.39M | $21.03M | $59.96M | $53.82M | $35.83M | $49.11M | $43.88M |
| Dividends paid | N/A | N/A | $3.83M | $1.68M | $5.86M | $7.56M | N/A | N/A | $0 | $400.00K |
| Share repurchases | $42.96M | $60.28M | $43.95M | $29.66M | $23.28M | $14.69M | $33.52M | $12.23M | $4.41M | $0 |
| Investing cash flow | -$13.41M | -$13.58M | -$4.55M | -$43.09M | -$94.66M | -$95.47M | -$44.30M | -$63.28M | -$123.97M | -$60.76M |
| Financing cash flow | -$40.37M | -$58.55M | -$41.86M | -$27.92M | -$22.20M | -$10.73M | -$31.62M | -$10.44M | $9.19M | $5.32M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $22.77M | $15.44M | $17.54M | $16.45M | $29.09M | $10.58M | $18.38M | $17.29M | $24.75M | $14.44M | $21.34M | $17.23M |
| Capital expenditures | $5.80M | $6.20M | $3.54M | $8.05M | $4.06M | $1.47M | $1.26M | $830.00K | $1.55M | $4.20M | $2.59M | $18.18M |
| Free cash flow | $16.97M | $9.24M | $14.00M | $8.40M | $25.03M | $9.12M | $17.12M | $16.46M | $23.20M | $10.25M | $18.75M | -$953.00K |
Frequently Asked Questions About PRLB
What is Proto Labs' annual revenue?
Proto Labs reported revenue of $533.13M for the fiscal year ended Dec 31, 2025.
How fast is Proto Labs' revenue growing?
Revenue was up 6.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 3.0%.
Is Proto Labs profitable?
Yes. Proto Labs reported net income of $21.24M for the fiscal year ended Dec 31, 2025, with a net margin of 4.0%.
How much free cash flow does PRLB generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $74.50M minus capital expenditures of $14.84M produced free cash flow of $59.66M.
How much debt does Proto Labs have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $1.44M and cash and equivalents of $110.83M.
PRLB pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts